More importantly, compared with previous studies, we originally revealed that PLVAP is markedly associated with immunosuppressive immunocyte infiltration degrees, inflammatory responses, and unfavorable survival of gliomas, which suggests that PLVAP may serve as a practicable marker and a promising target for glioma-based immunotherapy combined with anti-angiogenesis therapy. Here, PLVAP is linked to glioma.